Frank J.A. van den Hoogen

Dr. Frank J.A. van den Hoogen

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in Oral Oncology
Verified
Journal Article
Open access
WBWim van Boxtel
Wim van Boxtel
EBEline Boon
Eline Boon
WWWillem L.J. Weijs
Willem L.J. Weijs
FHFrank J.A. van den Hoogen
Frank J.A. van den Hoogen
UFUta E. Flucke
Uta E. Flucke
CHCarla van Herpen
Carla van Herpen

1 September 2016 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
SKSaskia Kok
Saskia Kok
JBJan J.W. van der Burg
Jan J.W. van der Burg
KHKaren van Hulst
Karen van Hulst
CECorrie E. Erasmus
Corrie E. Erasmus
FHFrank J.A. van den Hoogen
Frank J.A. van den Hoogen

1 August 2019 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
CDCorinne Delsing
Corinne Delsing
SBStijn Bekkers
Stijn Bekkers
KHKaren van Hulst
Karen van Hulst
CECorrie E. Erasmus
Corrie E. Erasmus
FHFrank J.A. van den Hoogen
Frank J.A. van den Hoogen

28 June 2024 in European Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
LOLynn B Orriëns
Lynn B Orriëns
SGSandra A F de Groot
Sandra A F de Groot
JBJan J W van der Burg
Jan J W van der Burg
FHFrank J.A. van den Hoogen
Frank J.A. van den Hoogen
KHKaren van Hulst
Karen van Hulst
CECorrie E Erasmus
Corrie E Erasmus
Anterior and posterior drooling are prevalent comorbidities in children with neurodevelopmental disabilities. Considering the heterogeneity of the patient population and the multifactorial aetiology of drooling, an interdisciplinary and individualised treatment approach is indispensable. However, no tool for stepwise decision-making in the treatment of paediatric drooling has been developed previously. Within the Radboudumc Amalia Children’s Hospital, care for children with anterior and/or posterior drooling secondary to neurodevelopmental disabilities is coordinated by a saliva control team with healthcare professionals from six disciplines. In alignment with international literature, published guidelines, and evidence gained from two decades of experience and research by our team, this paper proposes an algorithm reflecting the assessment and treatment approach applied in our clinic. First, directions are provided to decide on the necessity of saliva control treatment, taking type of drooling, the child’s age, and the severity and impact of drooling into account. Second, the algorithm offers guidance on the choice between available treatment options, highlighting the importance of accounting for child characteristics and child and caregiver preferences in clinical (shared) decision-making.Conclusions: With this algorithm, we aim to emphasise the importance of repeated stepwise decision-making in the assessment and treatment of drooling in children during their childhood, encouraging healthcare professionals to apply a holistic approach. What is Known:• Children with anterior or posterior drooling secondary to neurodevelopmental disabilities comprise a heterogeneous group, necessitating an individualised treatment approach.• No stepwise decision-making tool is available for the treatment of paediatric drooling. What is New:• Deciding on the necessity of saliva control treatment should be a conscious process, based on type of drooling, age, and drooling severity and impact.• Type of drooling, age, cognition, oral motor skills, self-awareness, posture, diagnosis, and child/caregiver preferences need to be considered to decide on the optimal treatment.

19 October 2023 in Perspectives on Medical Education
Verified
Journal Article
Open access
PDF file
PVPleuntje M. B. Verstegen
Pleuntje M. B. Verstegen
JKJ. J. (Jos) Kole
J. J. (Jos) Kole
AGA. Stef Groenewoud
A. Stef Groenewoud
FHFrank J.A. van den Hoogen
Frank J.A. van den Hoogen
Introduction: Official documentation of specialty training provides comprehensive and elaborate criteria to assess residents. These criteria are commonly described in terms of competency roles and entrustable professional activities (EPA’s), but they may also implicitly encompass virtues. Virtues are desirable personal qualities that enable a person, in this case, a medical specialist, to make and act on the right decisions. We articulate these virtues and explore the resulting implied ideal of a medical professional. Method: We applied a two-staged virtue ethical content analysis to analyze documents, specific to the Dutch training program of the Ear, Nose, and Throat (ENT) specialty. First, we identified explicit references to virtues. Next, we articulated implicit virtues through interpretation. The results were categorized into cardinal, intellectual, moral, and professional virtues. Results: Thirty virtues were identified in the ENT- training program. Amongst them, practical wisdom, temperance, and commitment. Furthermore, integrity, curiosity, flexibility, attentiveness, trustworthiness and calmness are often implicitly assumed. Notable findings are the emphasis on efficiency and effectiveness. Together, these virtues depict an ideal of a future medical specialist. Conclusion: Our findings suggest that competency-frameworks and EPA’s implicitly appeal to virtues and articulate a specific ideal surgeon. Explicit attention for virtue development and discussion of the role and relevance of implied ideal professionals in terms of virtues could further improve specialty training.

4 November 2023 in European Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
LOLynn B. Orriëns
Lynn B. Orriëns
KHKaren van Hulst
Karen van Hulst
JBJan J. W. van der Burg
Jan J. W. van der Burg
FHFrank J.A. van den Hoogen
Frank J.A. van den Hoogen
MWMichèl Willemsen
Michèl Willemsen
CECorrie E. Erasmus
Corrie E. Erasmus
Paediatric anterior drooling has a major impact on the daily lives of children and caregivers. Intraglandular botulinum neurotoxin type-A (BoNT-A) injections are considered an effective treatment to diminish drooling. However, there is no international consensus on which major salivary glands should be injected to obtain optimal treatment effect while minimizing the risk of side effects. This scoping review aimed to explore the evidence for submandibular BoNT-A injections and concurrent submandibular and parotid (i.e. four-gland) injections, respectively, and assess whether outcomes could be compared across studies to improve decision making regarding the optimal initial BoNT-A treatment approach for paediatric anterior drooling. PubMed, Embase, and Web of Science were searched to identify relevant studies (until October 1, 2023) on submandibular or four-gland BoNT-A injections for the treatment of anterior drooling in children with neurodevelopmental disabilities. Similarities and differences in treatment, patient, outcome, and follow-up characteristics were assessed. Twenty-eight papers were identified; 7 reporting on submandibular injections and 21 on four-gland injections. No major differences in treatment procedures or timing of follow-up were found. However, patient characteristics were poorly reported, there was great variety in outcome measurement, and the assessment of side effects was not clearly described. Conclusion: This review highlights heterogeneity in outcome measures and patient population descriptors among studies on paediatric BoNT-A injections, limiting the ability to compare treatment effectiveness between submandibular and four-gland injections. These findings emphasize the need for more extensive and uniform reporting of patient characteristics and the implementation of a core outcome measurement set to allow for comparison of results between studies and facilitate the optimization of clinical practice guidelines. What is Known:• There is no international consensus on which salivary glands to initially inject with BoNT-A to treat paediatric drooling. What is New:• Concluding on the optimal initial BoNT-A treatment based on literature is currently infeasible. There is considerable heterogeneity in outcome measures used to quantify anterior drooling.and clinical characteristics of children treated with intraglandular BoNT-A are generally insufficiently reported.• Consensus-based sets of outcome measures and patient characteristics should be developed and implemented.